You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SSRI/SNRI

Showing 1 - 25 of 411
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Depression, Depressive Disorder, Treatment-Resistant, Depressive Disorder Trial in Göteborg (OSU6162, Placebo)

Recruiting
  • Depression
  • +5 more
  • Göteborg, Västra Götaland, Sweden
    Sahlgrenska Universitetssjukhuset
Dec 6, 2022

MDD Trial (Low Dose 5-hydroxytryptophan, High Dose 5-hydroxytryptophan, Low Dose Creatine Monohydrate)

Not yet recruiting
  • Major Depressive Disorder
  • Low Dose 5-hydroxytryptophan
  • +4 more
  • (no location specified)
Jun 8, 2023

Following Menopause Treated WithNon-hormonal Therapy for Hot

Not yet recruiting
  • Hot Flashes
  • (no location specified)
Sep 18, 2023

Major Depressive Disorder With Anhedonia and Inadequate Response

Not yet recruiting
  • Depressive Disorder, Major
  • No Intervention
  • (no location specified)
Apr 24, 2023

Obesity, Depression Trial in Lucerne (Roux-en-Y gastric bypass, sleeve gastrectomy)

Completed
  • Obesity
  • Depression
  • Roux-en-Y gastric bypass, sleeve gastrectomy
  • Lucerne, Switzerland
    Luzerner Kantonsspital
Jun 9, 2021

MDD Trial in Salt Lake City (5-hydroxytryptophan and Creatine, Placebo control)

Terminated
Has Results
  • Major Depressive Disorder
  • 5-hydroxytryptophan and Creatine
  • Placebo control
  • Salt Lake City, Utah
    University of Utah
May 26, 2022

Psychiatric Orders in Psychoanalytic Treatment of ASD

Active, not recruiting
  • PTSD
  • +18 more
  • Psychoanalysis
  • +3 more
  • Chongqing, Chongqing, China
    Residential Address
Jun 26, 2023

MDD Trial in Salt Lake City (5-Hydroxytryptophan 100 MG, Creatine monohydrate, matched to 5-HTP)

Recruiting
  • Major Depressive Disorder
  • 5-Hydroxytryptophan 100 MG
  • +3 more
  • Salt Lake City, Utah
    University of Utah Department of Psychiatry
Apr 27, 2021

Risk Factors for AD-Associated Switch to Mania

Completed
  • Bipolar Disorder
  • Selective Serotonin Reuptake Inhibitors (SSRI), Serotonin-Norepinephrine Reuptake Inhibitor( SNRI), and Tricyclics.
  • Barcelona, Catalonia, Spain
    Hospital Clinic Barcelona
Nov 17, 2021

Anxiety Disorder, Healthy Trial in Tianjin (SSRI or SNRI or benzodiazepines or tricyclic antidepressants or other

Recruiting
  • Anxiety Disorder
  • Healthy
  • SSRI or SNRI or benzodiazepines or tricyclic antidepressants or other antidepressants or antipsychotics or other sedative-hypnotics
  • Neurofeedback system
  • Tianjin, China
    Tianjin Anding Hospital
Oct 17, 2021

Depressive Disorder, Major Trial in Worldwide (Esketamine, SSRI/SNRI)

Active, not recruiting
  • Depressive Disorder, Major
  • Ciudad Autonoma de Buenos Aires, Argentina
  • +58 more
Jan 31, 2023

Depressive Disorder, Major Trial in Worldwide (Esketamine 28 mg, Esketamine 56 mg, Esketamine 84 mg)

Completed
  • Depressive Disorder, Major
  • Esketamine 28 mg
  • +6 more
  • Ciudad Autonoma de Buenos Aires, Argentina
  • +170 more
Sep 13, 2022

Depressive Disorder, Major Trial in United States (JNJ-42847922, Placebo Matching to JNJ-42847922, Quetiapine XR)

Completed
Has Results
  • Depressive Disorder, Major
  • Phoenix, Arizona
  • +49 more
Jul 20, 2022

Depression Trial in Winston-Salem (Fluoxetine 20 MG, Duloxetine 30 MG, Observation)

Not yet recruiting
  • Depression
  • Fluoxetine 20 MG
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 28, 2023

Post-Traumatic Stress Disorder Trial (Nabiximols, Placebo)

Withdrawn
  • Post-Traumatic Stress Disorder
  • (no location specified)
Jun 2, 2022

Depressive Disorder, Major, Anhedonia Trial in Worldwide (Aticaprant, Placebo)

Recruiting
  • Depressive Disorder, Major
  • Anhedonia
  • Birmingham, Alabama
  • +156 more
Jan 31, 2023

Depressive Disorder, Major, Anhedonia Trial in Worldwide (Aticrapant, Placebo)

Recruiting
  • Depressive Disorder, Major
  • Anhedonia
  • Phoenix, Arizona
  • +72 more
Jul 10, 2022

Depressive Disorder, Anxiety Trial in Worldwide (JNJ-42165279, Placebo)

Completed
Has Results
  • Depressive Disorder
  • Anxiety
  • Costa Mesa, California
  • +31 more
Nov 9, 2022

Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)

Terminated
  • Depressive Disorder, Major
  • Phoenix, Arizona
  • +79 more
Oct 3, 2022

DaTSCAN Brain Scintigraphy and Psychotropic Treatments:

Not yet recruiting
  • Parkinson Disease
  • scintigraphy DaTSCAN
  • Vandœuvre-lès-Nancy, France
    CHRU Nancy
Jan 5, 2023

The Antidepressant Advisor: fMRI Study to Predict Treatment

Completed
  • Major Depressive Disorder
    • London, United Kingdom
      King's College London, IoPPN
    Jan 4, 2023

    Major Depressive Disorder Who Have HadInadequate Response

    Terminated
    • Depressive Disorder, Major
    • Standard of Care (SOC)
    • San Francisco, California
    • +3 more
    Dec 6, 2022

    Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)

    Recruiting
    • Depressive Disorder, Major
    • Phoenix, Arizona
    • +145 more
    Jan 31, 2023

    Depressive Disorder, Major Trial in Worldwide (Seltorexant, Matching to Seltorexant, Quetiapine XR)

    Recruiting
    • Depressive Disorder, Major
    • Birmingham, Alabama
    • +212 more
    Jul 20, 2022

    Bipolar Disorder Type II, Mood Depressive Disorder Trial in Clermont-Ferrand (NMR spectrometry)

    Recruiting
    • Bipolar Disorder Type II
    • Mood Depressive Disorder
    • NMR spectrometry
    • Clermont-Ferrand, France
      CHU clermont-ferrand
    Dec 6, 2022